Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700999 · ClinicalTrials.gov registry record · Phase 4
Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT00700999 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 65 participants.
The verdict
NCT00700999, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.
Interventions
- DRUG Paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00700999
The ClinicalTrials.gov registry entry for NCT00700999 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paroxetine is the first listed.
NCT00700999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00700999 about?
NCT00700999 is a clinical study titled "Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)". The purpose of this study is to examine if treatment of post-traumatic stress disorder in combat veterans with paroxetine changes brain responses as measured by functional magnetic resonance imaging and if brain responses can predict who will get better with treatment.
What is the current status of trial NCT00700999?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2008-10. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00700999?
The interventions under investigation include: Paroxetine (DRUG).
Who is sponsoring clinical trial NCT00700999?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.